Department of Clinical Pharmacokinetics, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan.
Evid Based Complement Alternat Med. 2012;2012:361516. doi: 10.1155/2012/361516. Epub 2012 Aug 27.
We have studied the effects of various Kampo medicines on P-glycoprotein (P-gp), a drug transporter, in vitro. The present study focused on Daiokanzoto (Da-Huang-Gan-Cao-Tang), which shows the most potent inhibitory effects on P-gp among the 50 Kampo medicines studied, and investigated the P-gp inhibitory effects of Daiokanzoto herbal ingredients (rhubarb and licorice root) and their components by an ATPase assay using human P-gp membrane. Both rhubarb and licorice root significantly inhibited ATPase activity, and the effects of rhubarb were more potent than those of licorice root. The content of rhubarb in Daiokanzoto is double that in licorice root, and the inhibition patterns of Daiokanzoto and rhubarb involve both competitive and noncompetitive inhibition, suggesting that the inhibitory effects of Daiokanzoto are mainly due to rhubarb. Concerning the components of rhubarb, concentration-dependent inhibitory effects were observed for (-)-catechin gallate, (-)-epicatechin gallate, and (-)-epigallocatechin gallate. In conclusion, rhubarb may cause changes in the drug dispositions of P-gp substrates through the inhibition of P-gp. It appears that attention should be given to the interactions between these drugs and Kampo medicines containing rhubarb as an herbal ingredient.
我们已经研究了各种汉方药对 P 糖蛋白(P-gp)的体外影响,P-gp 是一种药物转运蛋白。本研究重点关注大黄甘草汤(Da-Huang-Gan-Cao-Tang),它在研究的 50 种汉方药中对 P-gp 表现出最强的抑制作用,并通过使用人 P-gp 膜的 ATP 酶测定法研究了大黄甘草汤的草药成分(大黄和甘草根)及其成分的 P-gp 抑制作用。大黄和甘草根均显著抑制 ATP 酶活性,且大黄的作用强于甘草根。大黄甘草汤中大黄的含量是甘草根的两倍,且大黄甘草汤和大黄的抑制模式涉及竞争和非竞争抑制,表明大黄甘草汤的抑制作用主要归因于大黄。关于大黄的成分,(-)-儿茶素没食子酸酯、(-)-表儿茶素没食子酸酯和(-)-表没食子儿茶素没食子酸酯均表现出浓度依赖性抑制作用。总之,大黄可能通过抑制 P-gp 导致 P-gp 底物的药物处置发生变化。因此,应该注意这些药物与含有大黄作为草药成分的汉方药之间的相互作用。